GOSS

NASDAQ HEALTHCARE

Gossamer Bio Inc

$10.94

$0.01 (+0.09%)

Live quote

52w: $9.12 – $309.60

Loading chart…

P/E Ratio—

P/B Ratio—

EV/EBITDA—

Debt/Equity—

ROE—

ROIC—

Revenue Growth-57.74%

Gross Margin—

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapies in the areas of immunology, inflammation, and oncology diseases in the United States. The company is headquartered in San Diego, California.

Own GOSS? Track it here.

Create a free account to add GOSS to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account